Literature DB >> 11254601

Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells.

M L Mbow1, N Zeidner, R D Gilmore, M Dolan, J Piesman, R G Titus.   

Abstract

We previously showed that adoptive transfer of Borrelia burgdorferi-pulsed dendritic cells (DCs) into syngeneic mice protects animals from challenge with tick-transmitted spirochetes. Here, we demonstrate that the protective immune response is antibody (Ab) dependent and does not require the presence of major histocompatibility complex (MHC) class II molecules on DCs. Mice sensitized with B. burgdorferi-pulsed MHC class II-deficient (MHC class II(-/-)) DCs mounted a humoral response against protective antigens, including B. burgdorferi outer surface protein A (OspA) and OspC. B-cell help for the generation of neutralizing anti-OspC immunoglobulin G Abs could be provided by gammadelta T cells. In contrast, anti-OspA Ab production required the presence of alphabeta T cells, although this pathway could be independent of MHC class II molecules on antigen-presenting cells. Moreover, depletion of NK cells prior to transfer of antigen-pulsed MHC class II(-/-) DCs resulted in significant increases in the levels of neutralizing Abs induced by DCs. Altogether, these data suggest that the initial interactions between DCs and innate immune cells, such as gammadelta and NK cells, can influence the generation of a protective humoral response against B. burgdorferi antigens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254601      PMCID: PMC98173          DOI: 10.1128/IAI.69.4.2407-2415.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines.

Authors:  A Ronchetti; P Rovere; G Iezzi; G Galati; S Heltai; M P Protti; M P Garancini; A A Manfredi; C Rugarli; M Bellone
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

2.  Linking innate and adaptive immunity.

Authors:  K Palucka; J Banchereau
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

3.  Direct and indirect T cell priming by dendritic cell vaccines.

Authors:  S Cayeux; G Richter; C Becker; A Pezzutto; B Dörken; T Blankenstein
Journal:  Eur J Immunol       Date:  1999-01       Impact factor: 5.532

4.  Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.

Authors:  N C Fernandez; A Lozier; C Flament; P Ricciardi-Castagnoli; D Bellet; M Suter; M Perricaudet; T Tursz; E Maraskovsky; L Zitvogel
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

5.  Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease.

Authors:  R A Kalish; J M Leong; A C Steere
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

6.  An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31.

Authors:  M L Mbow; R D Gilmore; R G Titus
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.

Authors:  T G Schwan; J Piesman; W T Golde; M C Dolan; P A Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone.

Authors:  U E Schaible; R Wallich; M D Kramer; G Nerz; T Stehle; C Museteanu; M M Simon
Journal:  Int Immunol       Date:  1994-05       Impact factor: 4.823

9.  Exacerbation of Lyme arthritis in beige mice.

Authors:  S W Barthold; M de Souza
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

10.  The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis.

Authors:  E Akin; G L McHugh; R A Flavell; E Fikrig; A C Steere
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

View more
  5 in total

1.  Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection.

Authors:  Fleur Aline; Daniel Bout; Sébastian Amigorena; Philippe Roingeard; Isabelle Dimier-Poisson
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

2.  Evaluation of pathogen specific urinary peptides in tick-borne illnesses.

Authors:  Ruben Magni; Raghad Almofee; Sameen Yusuf; Claudius Mueller; Ngoc Vuong; Mahmood Almosuli; Minh Thu Hoang; Katherine Meade; Ish Sethi; Nuha Mohammed; Robyn Araujo; Teresa Kaza McDonald; Paul Marcelli; Virginia Espina; Brianna Kim; Anja Garritsen; Christine Green; Paul Russo; Weidong Zhou; Iosif Vaisman; Emanuel F Petricoin; Deborah Hoadley; Robert E Molestina; Hope McIntyre; Lance A Liotta; Alessandra Luchini
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

3.  Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.

Authors:  Zelda Euler; Marit J van Gils; Brigitte D Boeser-Nunnink; Hanneke Schuitemaker; Daniëlle van Manen
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

4.  Cross-reactive broadly neutralizing antibodies: timing is everything.

Authors:  Zelda Euler; Hanneke Schuitemaker
Journal:  Front Immunol       Date:  2012-07-20       Impact factor: 7.561

5.  Co-inoculation of Borrelia afzelii with tick salivary gland extract influences distribution of immunocompetent cells in the skin and lymph nodes of mice.

Authors:  J Severinová; J Salát; Z Krocová; J Reznícková; H Demová; H Horká; J Kopecký
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.